Use of ADNF polypeptides for treating peripheral neurotoxicity

Details for Australian Patent Application No. 2012200874 (hide)

International Classifications

Event Publications

1 March 2012 Complete Application Filed

8 March 2012 Application Open to Public Inspection

Published as AU-A-2012200874

3 May 2012 Section 223 Application Received

Ramot at Tel-Aviv University Ltd.; Allon Therapeutics, Inc. An application to extend the time from 26 Aug 2011 to 26 Feb 2012 in which to make a further application for a divisional patent has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

21 June 2012 Section 223 Application Allowed

Ramot at Tel-Aviv University Ltd. ; Allon Therapeutics, Inc. The time in which to make a further application for a divisional patent has been extended to 26 Feb 2012 . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Extensions of Time, Section 223

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.